Valuation (12%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | -1.56 | 36.14 |
| PEG Ratio (TTM) | -0.08 | 4.64 |
| P/S Ratio (TTM) | 6.42 | 5.07 |
| P/B Ratio (TTM) | 1.53 | 10.34 |
| P/FCF Ratio (TTM) | -1.67 | 25.55 |
| Price to 5YR AVG Earnings Ratio | N/A | 33.92 |
| Price to 5YR AVG FCF Ratio | N/A | 93.43 |
Profitability (0%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | -80.15% | 4.99% |
| ROE (TTM) | -97.03% | 20.60% |
| Net Profit Margin (TTM) | -304.91% | -30.30% |
| ROIC 5YR AVG | N/A | 81.64% |
Growth (50%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 23.12% | 20.96% | N/A |
| Revenue | 39.48% | 24.29% | N/A |
| Net Income | 13.09% | -37.22% | N/A |
| Cash Flow | 5.84% | -31.57% | N/A |
Health (21%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 2.79 | 1.97 |
| Quick Ratio (TTM) | 1.37 | 1.43 |
| D/E Ratio (TTM) | N/A | 1.20 |
| Interest Coverage (TTM) | N/A | 14.91 |
| Piotroski F-Score | 2 | 6 |
| Altman Z-Score | N/A | 4.51 |
| LTL to 5YR AVG FCF | N/A | 7.45 |
| Shares Outstanding Growth 5YR AVG | N/A | 13.58% |